Israel Englander Applied Molecular Transport Inc. Transaction History

Millennium Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.24 - $0.37 $32,577 - $50,223	-135,739 Reduced 83.59%	26,638 $6,000
Q1 2023 May 15, 2023	SELL	$0.32 - $0.68 $37,346 - $79,362	-116,709 Reduced 41.82%	162,377 $52,000
Q4 2022 Feb 14, 2023	BUY	$0.35 - $1.26 $16,658 - $59,969	47,595 Added 20.56%	279,086 $117,000
Q3 2022 Nov 14, 2022	BUY	$1.12 - $3.12 $5,311 - $14,795	4,742 Added 2.09%	231,491 $225,000
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $23,606 - $65,430	-8,553 Reduced 3.63%	226,749 $660,000
Q1 2022 May 16, 2022	SELL	$5.63 - $13.88 $1.81 Million - $4.47 Million	-321,691 Reduced 57.75%	235,302 $1.77 Million
Q4 2021 Feb 14, 2022	BUY	$13.23 - $26.05 $5.81 Million - $11.4 Million	438,829 Added 371.37%	556,993 $7.79 Million
Q3 2021 Nov 15, 2021	BUY	$25.87 - $46.61 $3.06 Million - $5.51 Million	118,164 New	118,164 $3.06 Million
Q1 2021 May 17, 2021	SELL	$30.5 - $74.14 $366,091 - $889,902	-12,003 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$29.39 - $35.0 $352,768 - $420,105	12,003 New	12,003 $369,000
Q3 2020 Nov 16, 2020	SELL	$20.49 - $33.58 $1.05 Million - $1.73 Million	-51,436 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.98 - $28.0 $924,819 - $1.44 Million	51,436 New	51,436 $1.29 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.